Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known ...
23, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical ...
Insilico Medicine has made headlines for discovering novel compounds for fibrosis using AI-generated models, further ...
A new statistical technique developed by a researcher at the Texas A&M University School of Public Health and colleagues ...
A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
A biotech that uses artificial intelligence to assist its drug discovery efforts has relocated its headquarters from New York ...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...
The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...
IPF is a rare progressive fibrosing interstitial lung disease with symptoms that include breathing difficulty, dry and persistent cough, chest discomfort and fatigue. The randomized, double-blind, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback